Select your Market

Global
Africa
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
Congo
Congo Democratic Republic
Djibouti
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Ivory Coast
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Reunion Islands
Rwanda
Saint Helena
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe
Asia
Bahrain
Bangladesh
China, mainland
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kuwait
Lebanon
Malaysia
Oman
Palestine
Philippines
Qatar
Saudi Arabia
Singapore
South Korea
Syria
Taiwan
Thailand
Turkey
United Arab Emirates
Vietnam
Yemen
Europe
Albania
Austria
Baltic Region
Belarus
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Netherlands
North Macedonia
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Türkiye
Ukraine
United Kingdom
Latin America
Argentina
Aruba
Bahamas
Barbados
Belize
Bolivia
Brazil
Central America
Chile
Colombia
Costa Rica
Cuba
Curacao-NL Antillen
Ecuador
El Salvador
Guatemala
Haiti
Honduras
Jamaica
Mexico
Nicaragua
Panama
Paraguay
Perú
República Dominicana
Trinidad and Tobago
Uruguay
Venezuela
North America
Canada
United States of America
Oceania
Australia
New Zealand
Global
CAREERS

News & Media

Explore the latest news from Merck KGaA, Darmstadt, Germany and stay up-to-date with our upcoming events.

Key figures

  • 21.1

    billion euro net sales in 2025

  • 6.1

    billion euro EBITDA pre in 2025

  • 62000

    employees around the world

    Latest News

    View all news

    1. Press Releases

      Merck KGaA, Darmstadt, Germany, Delivers Robust Q2 2026 Performance, Upgrades ...

      Performance driven by continued demand in Process Solutions, Rare Diseases and Semiconductor Solutions.

      2026/08/06

    2. Press Releases

      MilliporeSigma Announces BioReliance® Testing Facility Opening in ...

      MilliporeSigma's new €25M BioReliance® facility in Darmstadt expands release and stability testing for biopharma companies in Europe.

      2026/07/16

    3. Press Releases

      European Commission Approves Erbitux® (cetuximab) in Combination ...

      Merck KGaA, Darmstadt, Germany, announced that the European Commission (EC) approved an update to the Erbitux (cetuximab) EU label on June 26, 2026.

      2026/07/14

    Stay up-to-date

    You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe

    • Media Contacts

      for journalists, bloggers or multipliers.

      Get in touch!

    • Media downloads

      Browse and download high-quality images and video footage.
      Access gallery

    • Press Kits

      with all the facts and relevant background information on particularly important topics.

      Collected Topics

    This might also interest you

    • Strategy & Values

      We believe in science and technology as a force for good.

      Learn more

    • Stories

      Learn more about our company and the people behind it.

      Learn more

    • Sustainability

      We want to create long-term added value for society.

      Learn more

    • Our sites

      Learn where you can find us around the world.

      Learn more

    EVEN MORE INFORMATION

    Upcoming Events

    View All Events